Clonal haematopoiesis is not prevalent in survivors of childhood cancer

Br J Haematol. 2018 May;181(4):537-539. doi: 10.1111/bjh.14630. Epub 2017 Apr 3.

Grace Collord^{1

2}, Naomi Park¹, Marina Podestà³, Monica Dagnino³, Daniela Cilloni⁴, David Jones¹, Ignacio Varela⁵, Francesco Frassoni³, George S Vassiliou^{1

6

7}

¹ Wellcome Trust Sanger Institute, Cambridge, UK.
² Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
³ Laboratorio Cellule Staminali e Terapie Cellulari, Istituto Giannina Gaslini IRCCS, Genova, Italy.
⁴ Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
⁵ Instituto de Biomedicina y Biotecnología de Cantabria, Cantabria, Spain.
⁶ Department of Haematology, University of Cambridge, Cambridge, UK.
⁷ Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

No abstract available

Keywords: clonal evolution; haematopoiesis; haematopoietic stem cells; late effects of therapy; paediatric cancer.

Publication types